12 results · 18ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

SubtleHD-CT (1.x)

FDA 510(k)
FDA Class 2 ·Radiology

Impact™

FDA UDI
B BRAUN INTERVENTIONAL SYSTEMS, INC·04046964291371·IMPACT 25MMX4CMX120CM

APEX Knee System

FDA UDI
Omni Life Science, Inc.·00841690199373·Revision Knee Spiral Reamer- Hudson Long Flutes...

Alleset

FDA UDI
GRI Medical & Electronic Technology Co., Ltd.·16931918143699·Bandage, Esmark, Blue, Powderless, 4inx144in_No...

Alleset

FDA UDI
GRI Medical & Electronic Technology Co., Ltd.·16931918184623·Esmark Bandage_4inx144in_Sterile_20ea/cs

ORION

FDA UDI
HNM TOTAL RECON LLC·00841742141213·ORION ø2.5mm Headless Cannulated Screw, Short T...

GSS610N21 Series Steam Sterilizer

FDA 510(k)
FDA Class 2 ·General Hospital

GECHO

FDA 510(k)
FDA Class 2 ·Radiology

CONTAK RENEWAL 3

FDA Adverse Event
Injury ·CARDIAC PACEMAKERS, INC·Product code NIK·November 11, 2008

COLLEAGUE

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - SINGAPORE·Product code FRN·September 19, 2011

GYNECARE TVT OBTURATOR SYSTEM

FDA Adverse Event
Injury ·ETHICON INC.·Product code OTN·July 30, 2013

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014